167 related articles for article (PubMed ID: 38284661)
21. The current evidence in support of multimodal treatment of locally advanced, potentially resectable esophageal cancer.
Zacherl J
Dig Dis; 2014; 32(1-2):171-5. PubMed ID: 24603404
[TBL] [Abstract][Full Text] [Related]
22. Analysis of patients scheduled for neoadjuvant therapy followed by surgery for esophageal cancer, who never made it to esophagectomy.
Depypere L; Thomas M; Moons J; Coosemans W; Lerut T; Prenen H; Haustermans K; Van Veer H; Nafteux P
World J Surg Oncol; 2019 May; 17(1):89. PubMed ID: 31133018
[TBL] [Abstract][Full Text] [Related]
23. VEGF-C expression in squamous cell carcinoma and adenocarcinoma of the esophagus.
Möbius C; Freire J; Becker I; Feith M; Brücher BLDM; Hennig M; Siewert JR; Stein HJ
World J Surg; 2007 Sep; 31(9):1768-1772. PubMed ID: 17354029
[TBL] [Abstract][Full Text] [Related]
24. Early esophageal cancer: the significance of surgery, endoscopy, and chemoradiation.
Mönig S; Chevallay M; Niclauss N; Zilli T; Fang W; Bansal A; Hoeppner J
Ann N Y Acad Sci; 2018 Dec; 1434(1):115-123. PubMed ID: 30138532
[TBL] [Abstract][Full Text] [Related]
25. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?
Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K
Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755
[TBL] [Abstract][Full Text] [Related]
26. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.
Schneider PM; Baldus SE; Metzger R; Kocher M; Bongartz R; Bollschweiler E; Schaefer H; Thiele J; Dienes HP; Mueller RP; Hoelscher AH
Ann Surg; 2005 Nov; 242(5):684-92. PubMed ID: 16244542
[TBL] [Abstract][Full Text] [Related]
27. Distant Oncologic Outcome of Patients with Locally Advanced Unresectable and Metastatic Esophageal Cancer after Multimodality Treatment.
Anghel R; Constantinoiu S; Bacinschi X; Gales L; Toma RV; Trifanescu O
Chirurgia (Bucur); 2018; 113(1):116-122. PubMed ID: 29509538
[No Abstract] [Full Text] [Related]
28. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
[TBL] [Abstract][Full Text] [Related]
29. Comparison of salvage chemoradiation versus salvage surgery for recurrent esophageal squamous cell carcinoma after definitive radiochemotherapy or radiotherapy alone.
Chen Y; Lu Y; Wang Y; Yang H; Xia Y; Chen M; Song H; Li T; Li D; Wang J; Li S; Wang J
Dis Esophagus; 2014; 27(2):134-40. PubMed ID: 23088212
[TBL] [Abstract][Full Text] [Related]
30. Resection of a Submucosal Tumor-Like Superficial Carcinoma in Middle Thoracic Esophagus Concomitant with Mucosal Adenocarcinoma and Submucosal Squamous Cell Carcinoma: A Case Report and Review of Literature.
Yamamoto S; Kumaki N; Makuuchi H; Ozawa S; Shimada H; Chino O; Kazuno A; Yasuda S; Tamayama T; Sakai I
Tokai J Exp Clin Med; 2015 Sep; 40(3):96-103. PubMed ID: 26369262
[TBL] [Abstract][Full Text] [Related]
31. Endoscopic ultrasound for esophageal and gastroesophageal junction cancer: Impact of increased use of primary neoadjuvant therapy on preoperative locoregional staging accuracy.
DeWitt J; Kesler K; Brooks JA; LeBlanc J; McHenry L; McGreevy K; Sherman S
Dis Esophagus; 2005; 18(1):21-7. PubMed ID: 15773837
[TBL] [Abstract][Full Text] [Related]
32. Individualized surgical strategies for cancer of the esophagogastric junction.
Stein HJ; Feith M; Siewert JR
Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
[TBL] [Abstract][Full Text] [Related]
33. Survival of patients with carcinoma of the esophagus treated with combined-modality therapy.
Wolfe WG; Vaughn AL; Seigler HF; Hathorn JW; Leopold KA; Duhaylongsod FG
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):749-55; discussion 755-6. PubMed ID: 8469009
[TBL] [Abstract][Full Text] [Related]
34. Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity.
Paireder M; Jomrich G; Kristo I; Asari R; Rieder E; Beer A; Ilhan-Mutlu A; Preusser M; Schmid R; Schoppmann SF
Strahlenther Onkol; 2020 Sep; 196(9):779-786. PubMed ID: 32055873
[TBL] [Abstract][Full Text] [Related]
35. Locally advanced esophageal carcinoma: is there still a role of surgery alone without neoadjuvant treatment?
Reeh M; Nentwich MF; Asani S; Uzunoglu FG; Bockhorn M; Sauter G; Rösch T; Izbicki JR; Bogoevski D
J Gastrointest Surg; 2015 Apr; 19(4):587-93. PubMed ID: 25652343
[TBL] [Abstract][Full Text] [Related]
36. [Non-metastatic oesophageal cancer: diagnosis and treatment].
Voeten DM; den Bakker CM; Goedegebuure RSA; Heineman DJ; Daams F; van der Peet DL
Ned Tijdschr Geneeskd; 2019 Sep; 163():. PubMed ID: 31556490
[TBL] [Abstract][Full Text] [Related]
37. Updates in staging and pathologic evaluation of esophageal carcinoma following neoadjuvant therapy.
Zhang X; Jain D
Ann N Y Acad Sci; 2020 Dec; 1482(1):163-176. PubMed ID: 32892349
[TBL] [Abstract][Full Text] [Related]
38. Esophageal cancer and Barrett's esophagus. How to approach surveillance, treatment, and palliation.
Shahin W; Murray JA
Postgrad Med; 1999 Jun; 105(7):111-4, 119-22, 125-7. PubMed ID: 10376054
[TBL] [Abstract][Full Text] [Related]
39. Collision carcinoma of the residual cervical esophagus 27 years after esophageal cancer surgery.
Naritaka Y; Ogawa K; Shimakawa T; Wagatsuma Y; Isohata N; Asaka S; Miyaki A; Shiozawa S; Katsube T; Yoshimatsu K; Aiba M; Ide H
Anticancer Res; 2007; 27(1B):505-11. PubMed ID: 17348434
[TBL] [Abstract][Full Text] [Related]
40. Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer.
Lutz MP; Zalcberg JR; Ducreux M; Ajani JA; Allum W; Aust D; Bang YJ; Cascinu S; Hölscher A; Jankowski J; Jansen EP; Kisslich R; Lordick F; Mariette C; Moehler M; Oyama T; Roth A; Rueschoff J; Ruhstaller T; Seruca R; Stahl M; Sterzing F; van Cutsem E; van der Gaast A; van Lanschot J; Ychou M; Otto F;
Eur J Cancer; 2012 Nov; 48(16):2941-53. PubMed ID: 22921186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
